Archived Facts

Drugmaker Pfizer Inc. is extending by a day its tender offer for pain drug developer Icagen, after the number of shares tendered by Wednesday’s deadline fell just short of what Pfizer needed.

Popular Posts:

Related Posts:

Leave a Reply